Inhibition of the anti-apoptotic proteins favors tumor growth suppression, as Bcl-2 inhibition sensitizes colon cancer cells to death [40], and mice deficient in Bcl-xL have reduced intestinal tumor burden [41]. This evidence concerns the gene BCL2 and colonic neoplasm.